What did @gcoobs10 actually say?
She claims six weeks on two peptide protocols, one called "rotary tide" (likely Rotifera or, more plausibly, a compounded variant she's mispronouncing) and a blend of "test of Morellan, AOD-9604, and Moxie," reduced her IBS-related bloating, cut cravings, and boosted energy. She's also promoting a specific med clinic in Port Orange, Florida, with a 10-25% affiliate discount using her name.
To her credit, she's not claiming dramatic weight loss from peptides alone. She explicitly says she still eats and works out. She also frames the clinic's doctor consultation as a feature, not a footnote. Those are better-than-average disclosures for TikTok peptide content. But some of what she's describing, like the peptide names themselves, is garbled enough to make it hard to verify exactly what she's taking, which is a real problem.
Does the science back this up?
Partly, but the evidence base is thin and almost entirely preclinical. AOD-9604 has the most documented history here. It's a modified fragment of human growth hormone (hGH 176-191) originally developed by Metabolic Pharmaceuticals. Early trials showed fat metabolism effects in obese patients, but later Phase II and III trials failed to meet primary endpoints, and the FDA has not approved it for weight loss. That's not a rumor. That's the public record.
For the GH secretagogue blend she's describing (likely CJC-1295 and ipamorelin, which are commonly sold as a "Morellan"-type stack at compounding clinics), there's more legitimate clinical rationale. Ipamorelin selectively stimulates GH release with fewer cortisol side effects than earlier secretagogues (Raun et al., 1998, European Journal of Endocrinology). CJC-1295 extends GH pulse duration. Together, the theoretical synergy is real. But long-term safety data in healthy, non-GHD adults is sparse. The IBS claim has essentially no peptide-specific trial support.
What did they get wrong (or right)?
The bloating-and-IBS claim is the shakiest part of this video. She says "I have felt no bloating" since starting peptides, and while BPC-157 has shown gut-healing properties in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), she isn't clearly on BPC-157. Attributing IBS symptom relief to AOD-9604 or a GH secretagogue blend has no credible mechanistic basis in the published literature. It's also possible her symptoms improved for unrelated reasons over six weeks.
The charger analogy she uses to justify sourcing from a compounding clinic over online vendors is actually directionally correct. Compounding pharmacies operating under USP 797 standards provide sterile peptides with documented purity. Random online "research chemical" vendors do not. That distinction matters. However, calling it a "med clinic" making things on site blurs the line between a licensed compounding pharmacy and something else entirely, and consumers should ask specifically whether the facility is a 503A or 503B compounder registered with state pharmacy boards.
What should you actually know?
If you're considering peptides after watching this, here's what this video doesn't tell you. AOD-9604 failed its pivotal weight-loss trials and was reclassified by the FDA. Compounded versions exist in a legal gray area. GH secretagogue stacks like CJC-1295 and ipamorelin are not FDA-approved for fat loss or energy in healthy adults. They're prescribed off-label by clinics, which is legal, but "a doctor called me" is not the same as a full metabolic workup.
The affiliate discount structure here, 10-25% off if you say her name, means she has a financial relationship with this clinic. That doesn't make her wrong, but it means you're watching a paid promotion with a wellness anecdote attached. The FTC requires disclosure of material connections. A discount code linked in bio qualifies. Viewers should weigh that accordingly before taking medical cues from a six-week TikTok testimonial, however genuine it sounds.